3,500
Participants
Start Date
August 31, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
September 1, 2026
Investigational Procedure
"It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands.~Study without any Investigational Medicinal Product (IMP) administration."
Lead Sponsor
Sanofi
INDUSTRY